206 patient levilimab late treatment RCT:70% lower ICU admission (p=0.08) and 65% greater improvement (p<0.0001). RCT 206 severe COVID-19 patients not requiring mechanical ventilation, showing higher sustained clinical improvement and lower ICU admission with levilimab. There was no difference in mortality. Sep 2021, Inflammation Research, https://link.springer.com/10.1007/s00011-021-01507-5, https://c19p.org/lomakin
